Paasa Logo
Samil Pharmaceutical Co.,Ltd logo
000520KRXMarket closedOpens 9:00am KST

Samil Pharmaceutical Co.,Ltd

₩8,350.00Last updated
-₩180.00 (2.11%)Past day
Timezone

Samil Pharmaceutical Co.,Ltd (KRX: 000520) is trading at ₩8,350.00, about ₹603 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 2.11% today. Samil Pharmaceutical is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.

Quote

Open:₩8,530.00
Previous close:₩8,530.00
Volume:47.47K

Today's low

₩8,280.00

Today's high

₩8,560.00

52 week low

₩5,500.00

52 week high

₩12,860.00

000520 opened at ₩8,530.00, closed previously at ₩8,530.00, and has traded between ₩5,500.00 and ₩12,860.00 over the past 52 weeks.

About

Samil Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company founded in 1947 that develops, manufactures, and sells a range of healthcare products. While its portfolio includes various medicines and medical devices, it has a particular specialization in ophthalmology (eye care). The company engages in the development of new drugs and also provides Contract Development and Manufacturing Organisation (CDMO) services.

Country
KR
CEO
Seung Bum Huh
Exchange listed on
KRX
Industry
Drug Manufacturers - Specialty & Generic
Base currency
KRW
Full Time Employees
585
Sector
Healthcare
IPO date
28/05/1985

Key statistics

Avg. volume

110.58K

Market cap

₩178.44B

P/E Ratio

-4.73

Price-to-sales ratio

0.86

Enterprise value

₩363.49B

Free cash flow yield

-6.57%

Debt-to-equity ratio

1.40

Return on equity

-25.96%

ROIC

-6.80%

Beta

0.34

Dividend yield

0.00%

Last dividend

₩0.00

Financial overview

Revenue

₩210.37B

Earnings per share

-₩1,627.95

Free cash flow

-₩13.52B

Net profit margin

-18.09%

Gross margin

32.13%

EBITDA

-₩10.72B

Revenue growth

-4.25%

Similar securities

This is not an investment recommendation

Samil Pharmaceutical for Indian investors

Samil Pharmaceutical is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.

Taxes on Samil Pharmaceutical for Indian residents

Trading and limits

Trading hours
9:00 am – 3:30 pm KST
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneSamil Pharmaceutical does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained

FAQs

Can I buy Samil Pharmaceutical on Paasa?

Samil Pharmaceutical (000520) has been listed on the Korea Exchange since 1985, in the Drug Manufacturers - Specialty & Generic industry. Samil Pharmaceutical is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.

How much does one Samil Pharmaceutical share cost in rupees?

One Samil Pharmaceutical share is ₩8,350.00 — about ₹603 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Samil Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for investing abroad from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.

How are gains on Samil Pharmaceutical shares taxed in India?

Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Samil Pharmaceutical price.

Does Samil Pharmaceutical pay a dividend?

No. Samil Pharmaceutical does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one: dividends are taxed at your slab rate in India.

When does KRX trade, in Indian time?

The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.

Do I have to declare Samil Pharmaceutical shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.

Does the rupee rate affect what I make on Samil Pharmaceutical?

Yes. Samil Pharmaceutical is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.